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The patent pending PAIA technology provides a novel
platform for the quantification of proteins, e.g. monoclo-
nal antibodies. PAIA assays consist of functionalized
beads to capture the protein of interest (the analyte) and
a fluorescent marker to detect the analyte. In contrast to
other bead-based assays, which measure the fluorescence
intensity of marker that is bound to the beads [1], PAIA
assays measure the fluorescence of unbound marker
remaining in solution. We use protrusions on the bottom
of the microplate that separate captured analyte-marker
complexes from unbound fluorescent marker. Therefore,
no washing steps are needed and the assay can be per-
formed in an automation-friendly 384-well plate format
(Figure 1A).The time to result, the amount of sample
required, and the hands-on time are substantially
reduced compared to other immunoassay formats.
Hence, this novel approach is particularly suitable for
high throughput analysis of protein containing samples
like supernatants of antibody producing cells.
Material and methods
The PAIA platform is based on 384-well plates and all
assays were performed in a volume of 60 µL. If not stated
otherwise, a sample volume of 6 µL was used. The sam-
ple as well as fluorescence marker in reaction buffer were
added to the microplate which contained dried capture
beads. After addition of buffer and sample, the micro-
plate was incubated for 30minutesat 2000 rpm on an
orbital shaker at room temperature and subsequently
allowed to stand for 10-15 minutes. The read-out is
obtained with either a plate reader or a fluorescence
microscope (SynenTec, Elmshorn, Germany) in less than
five minutes per plate. The data depicted in Figure 1D
was obtained by incubating the assay on the BioSha-
keXP (Q.Instruments, Jena, Germany) at 1800 rpm
for 40 minutes, followed by 5 minutes at 1000 rpm
and 10 minutes without agitation. The protrusion on the
microplate bottom ensures that the beads are settling out-
side the detection window. Hence, only the unbound
fluorescent marker was detected when measuring on a
fluorescence plate reader in bottom read modus at
485/520 nm (Safire, Tecan, Männedorf, Switzerland).
Calibration curves were calculated in the PAIA evaluation
software with a 4-parameter fit.
Results and discussion
PAIA assays offer the possibility to choose a marker
against the specific epitope of the analyte that shall be
detected. For example, in a PAIA assay to quantify
human IgG1, Protein A beads capture the Fc part of IgG
and the fluorescent marker can be directed either against
the whole antibody or against specific regions like the
Fab fragment or the light chain. The PAIA Human IgG
Fc/Fab assay kit uses a marker targeting the Fab region of
human IgG. Due to the Protein A capture, the assay is
suitable for IgG1, IgG2 (Figure 1B) and IgG4 (data not
shown). The curves reflect different affinities of Protein
A and fluorescence marker to the IgGs. In addition, the
IgG assay was tested for influences of cell culture media
and supernatants of HEK and CHO cells. The raw data
signal was slightly elevated in most samples. However,
when the calibration standards are prepared in the same
matrix as the samples almost no difference is detected
(Figure 1C). The performance values of this assay are dis-
played in Table 1. An IgG1 concentration range of about
5 - 200 μg/mL is covered in the assay when using 6 µL
sample. Variation of the sample volume allows adjust-
ment of the dynamic range to the expected analyte con-
centration (Figure 1D). One plate can be processed in an* Correspondence: christine.wosnitza@paiabio.com
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hour; the throughput can be increased by the use of mul-
tiple shakers in parallel. Due to the standardized plate
format and the simple mix-and-measure protocol the
assay can be easily run in an automated setup.
Conclusions
We believe that the high throughput, the small sample
volume, and the low overall costs represent substantial
advantages over existing methods. In future, we will
expand the range of assays to other proteins to fully
exploit the potential of this versatile technique.
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Figure 1 PAIA Human IgG Fc/Fab assay.(a) Description of the PAIA assay workflow: Each of the wells of the 384 well PAIA plate contains pre-
dispensed dried capture beads. The depicted procedure is run in parallel in each of the wells. The unique structure of the plate allows detection of
the unbound fluorescence marker only through the transparent protrusion which keeps the beads outside the detection zone and light path.
(b) IgG1 and IgG2 quantification in buffer. (c) IgG1 quantification in cell culture media. It is recommended to prepare standards and samples in the
same matrix. Medium 1: Gibco Freestyle CHO + 8 mM Glutamax, Medium 2: BD Select CHO + 8 mM L-Ala-L-Gln, Medium3: Biochrome ISF-1 + 10%
FBS. (d) IgG1 calibration curves for several sample volumes. The dynamic range is adapted to higher (2 μL) or lower (10 μL) IgG concentrations by
the variation of sample volume.
Table 1. Performance values of the Human IgG Fc/Fab
assay
Sample volume 6 μL
Assay volume 60 μL
IgG concentration 5 - 200 μg/mL
Limit of detection ~ 5 μg/mL
CV ~ 10%
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